Amplia Therapeutics (@ampliatx) 's Twitter Profile
Amplia Therapeutics

@ampliatx

Amplia Therapeutics Limited (ASX:ATX) is a Melbourne-based biopharmaceutical company focused on the clinical development of novel oncology drugs.

ID: 790322585045127168

linkhttp://www.ampliatx.com/ calendar_today23-10-2016 22:42:42

309 Tweet

336 Takipçi

56 Takip Edilen

Amplia Therapeutics (@ampliatx) 's Twitter Profile Photo
Amplia Therapeutics
@ampliatx

3 months ago

$ATX | #Amplia has received US ethics approval to initiate a Phase 2 clinical trial of narmafotinib in combination with FOLFIRINOX chemotherapy for advanced pancreatic cancer patients. Read the ASX release: bit.ly/ATX-US-Ethics  #biotech #pancreaticcancer #clinicaltrial #ASX

$ATX | #Amplia has received US ethics approval to initiate a Phase 2 clinical trial of narmafotinib in combination with FOLFIRINOX chemotherapy for advanced pancreatic cancer patients. Read the ASX release: bit.ly/ATX-US-Ethics  #biotech #pancreaticcancer #clinicaltrial #ASX